Moderna Inc’s recent filing unveils that its Chief Financial Officer Mock James M unloaded Company’s shares for reported $42986.0 on Oct 07 ’24. In the deal valued at $60.12 per share,715 shares were sold. As a result of this transaction, Mock James M now holds 9,505 shares worth roughly $0.51 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Klinger Shannon Thyme sold 551 shares, generating $40,539 in total proceeds. Upon selling the shares at $73.57, the Chief Legal Officer now owns 18,154 shares.
Before that, Klinger Shannon Thyme bought 551 shares. Moderna Inc shares valued at $40,539 were divested by the Officer at a price of $73.57 per share.
Bernstein initiated its Moderna Inc [MRNA] rating to a Mkt perform in a research note published on October 17, 2024; the price target was $55. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who decreased its forecast for the stock in mid September from “an Outperform” to “a Perform”. JP Morgan also remained covering MRNA and has decreased its forecast on September 13, 2024 with a “an Underweight” recommendation from previously “Neutral” rating. Jefferies revised its rating on September 13, 2024. It rated MRNA as “a Hold” which previously was an “a Buy”.
Price Performance Review of MRNA
On Monday, Moderna Inc [NASDAQ:MRNA] saw its stock fall -0.55% to $53.80. Over the last five days, the stock has lost -6.81%. Moderna Inc shares have fallen nearly -45.90% since the year began. Nevertheless, the stocks have fallen -34.68% over the past one year. While a 52-week high of $170.47 was reached on 05/24/24, a 52-week low of $53.55 was recorded on 10/21/24. SMA at 50 days reached $70.27, while 200 days put it at $102.71.
Levels Of Support And Resistance For MRNA Stock
The 24-hour chart illustrates a support level at 52.98, which if violated will result in even more drops to 52.16. On the upside, there is a resistance level at 54.69. A further resistance level may holdings at 55.58. The Relative Strength Index (RSI) on the 14-day chart is 23.95, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.67, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.95%. Stochastics %K at 8.44% indicates the stock is a buying.
How much short interest is there in Moderna Inc?
A steep rise in short interest was recorded in Moderna Inc stocks on 2024-09-30, growing by 5.69 million shares to a total of 31.32 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 25.63 million shares. There was a rise of 18.17%, which implies that there is a positive sentiment for the stock.
